Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;40(11):1634-1643.
doi: 10.1038/s41372-020-00788-8. Epub 2020 Aug 18.

Novel biomarkers of bronchopulmonary dysplasia and bronchopulmonary dysplasia-associated pulmonary hypertension

Affiliations

Novel biomarkers of bronchopulmonary dysplasia and bronchopulmonary dysplasia-associated pulmonary hypertension

Mitali Sahni et al. J Perinatol. 2020 Nov.

Abstract

Objective: To quantify and compare levels of potential biomarkers in neonates with (i) Bronchopulmonary dysplasia (BPD); (ii) BPD-associated pulmonary hypertension (BPD-PH); (iii) PH without BPD; and (iv) neonates without lung disease at ~36 weeks postmenstrual age.

Study design: Multiple potential biomarkers were measured in plasma samples of 90 patients using a multi-spot enzyme-linked immunosorbent assay. Statistical tests done included one-way ANOVA to compare levels of biomarkers between different groups.

Results: Higher levels of ICAM-1 were present in infants with BPD and correlated with its severity. Infants with BPD have significantly higher levels of ANG-2 and lower levels of ANG-1. Infants with PH have higher levels of: IL-6, IL-8, IL-10, and TNF-α. Infants with BPD-PH have significantly lower levels of MCP-1 and higher levels of IL-1β than infants with PH without BPD.

Conclusion: ICAM-1 may be used as a specific biomarker for diagnosis of BPD and its severity.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors declare no conflicts of interest.

Figures

Figure 1-
Figure 1-
Biomarkers in PC, TC, BPD, PHTN and BPD-PH (Discovery cohort): A)Elevated levels of ICAM-1 as compared to PC, TC and BPD-PH. ICAM levels also correlate with severity of BPD (p=0.0047). B) Infants with BPD have higher level of Ang2 and lower level of Ang1.
Figure 2-
Figure 2-
Biomarkers in PC, TC, BPD, PHTN and BPD-PH (Discovery cohort): A) Higher levels of IL-1β and lower level of MCP-1 were seen in BPD-PH as compared to PHTN and, TC.
Figure 3-
Figure 3-
Biomarkers in PC, TC, BPD, PHTN and BPD-PH (Discovery cohort): Specific cytokines (IL6, IL8, IL10 and TNFα) were significantly increased in infants with PH, compared to TC.
Figure 4-
Figure 4-
Biomarkers in BPD (validation cohort vs. discovery cohort): A)Elevated levels of ICAM-1 in both BPD groups as compared to PC. B, C & D) Higher levels of IL-1β, IL-6 and TNF-α in BPD-NW as compared to BPD-SC and PC. E) Lower levels of IL-8 in BPD-NW as compared to BPD-SC.

References

    1. Bhandari A, Bhandari V. Biomarkers in bronchopulmonary dysplasia. Paediatric respiratory reviews 2013, 14(3): 173–179. - PubMed
    1. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. American journal of respiratory and critical care medicine 2001, 163(7): 1723–1729. - PubMed
    1. Lal CV, Ambalavanan N. Biomarkers, Early Diagnosis, and Clinical Predictors of BPD. Clinics in perinatology 2015, 42(4): 739–754. - PMC - PubMed
    1. Piersigilli F, Lam TT, Vernocchi P, Quagliariello A, Putignani L, Aghai ZH, et al. Identification of new biomarkers of bronchopulmonary dysplasia using metabolomics. Metabolomics 2019, 15(2): 20. - PubMed
    1. Piersigilli F, Bhandari V. Biomarkers in neonatology: the new “omics” of bronchopulmonary dysplasia. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet 2016, 29(11): 1758–1764. - PubMed

Publication types

LinkOut - more resources